Yoomi Yeo

Yoomi Yeo

Auto-generated profile, based on publicly available information

Yoomi Yeo

Department of Internal Medicine, Hanyang University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2025 in International Journal of Chronic Obstructive Pulmonary Disease
Verified
Journal Article
Open access
PDF file
KHKyung-Il Han
Kyung-Il Han
YYYoomi Yeo
Yoomi Yeo
HJHang Joon Jo
Hang Joon Jo
MJMin Ju Jo
Min Ju Jo
YPYeonkyung Park
Yeonkyung Park
TKTae-Hyung Kim
Tae-Hyung Kim
Background: Cognitive impairment is a major comorbidity of chronic obstructive pulmonary disease (COPD), but the underlying mechanisms are not fully understood. In this study, we used resting-state functional magnetic resonance imaging to investigate brain functional connectivity (FC) abnormalities in patients with COPD and explored the correlation between abnormal FC and COPD-related clinical parameters. Methods: Forty-one patients with COPD, without a definite diagnosis of cognitive impairment or depression, and 30 age- and sex-matched controls were recruited. A total of 184 resting-state functional connectivity (RSFC) maps were generated for all seed points. Welch’s t-test was used to assess differences in RSFC between the COPD and control groups, and the correlation coefficients between RSFC and clinical parameters were calculated. Results: Patients with COPD had lower scores on the Mini-Mental State Exam (MMSE) and Korean version of the Montreal Cognitive Assessment and higher scores on the Beck Depression Inventory than the control group. Additionally, patients with COPD showed decreased RSFC in the left middle-posterior cingulate cortex, left posterior-dorsal cingulate cortex, and right superior occipital gyrus and increased RSFC in the left superior temporal sulcus, left posterior transverse collateral sulcus, right occipital pole, and right precentral gyrus. The regions showing differences in FC correlated with MMSE score, COPD symptom assessment scales, such as the COPD Assessment Test and modified Medical Research Council Dyspnea Scale, and pulmonary function parameters, including forced expiratory volume in one second and forced vital capacity. Conclusion: Patients with COPD showed significant differences in FC within specific brain regions that correlated with symptoms, cognition, and lung function.

1 October 2021 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
Youlim KimYoulim Kim
Youlim Kim
Hyun LeeHyun Lee
Hyun Lee
SCSung Jun Chung
Sung Jun Chung
YYYoomi Yeo
Yoomi Yeo
TPTai Sun Park
Tai Sun Park
HYHo Joo Yoon
Ho Joo Yoon
Background and Objective: Despite the usefulness of airway hyperresponsiveness (AHR) testing in diagnosing and monitoring asthma, it is challenging to perform in a real-world setting. Forced expiratory flow between 25% and 75% of vital capacity (FEF25– 75), a pulmonary measurement that can be obtained easily during routine spirometry, represents the status of medium-sized and small airways. However, the performance of FEF25– 75 in predicting AHR has not been well elucidated. Therefore, we investigated whether FEF25– 75 can predict AHR to mannitol. Methods: We performed a retrospective cohort study of 428 patients who visited a single clinic due to cough, wheezing, or dyspnea. All patients underwent spirometry with a mannitol provocation test. We compared the area under the curve (AUC) of the percentage of the predicted values of FEF25– 75 (FEF25– 75 %pred) with that of forced expiratory volume in 1 second (FEV1%pred), FEV1/forced vital capacity (FVC), and FEF25– 75/ FVC for predicting AHR. Results: The rate of AHR to mannitol was 20.3%. In the overall study population, the AUC of FEF25– 75 %pred for predicting AHR (0.772; 95% confidence interval [CI], 0.729– 0.811) was significantly higher than that of FEV1%pred (0.666; 95% CI, 0.619– 0.710; p < 0.001), FEV1/FVC (0.741; 95% CI, 0.697– 0.782; p = 0.047), and FEF25– 75/FVC (0.741, 95% CI = 0.696– 0.782, p = 0.046). The sensitivity, specificity, positive predictive value, and negative predictive value of FEF25– 75 %pred < 81% for predicting AHR in the overall study population were 77.0% (95% CI = 66.8– 85.4%), 63.9% (95% CI = 58.6– 69.0), 35.3%, and 91.6%, respectively. When we restricted the study group to subjects with normal lung function, the results were similar. Conclusion: Our results indicate that FEF25– 75 %pred can be used as a surrogate for predicting AHR in patients with respiratory symptoms.

1 January 2021 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
Youlim KimYoulim Kim
Youlim Kim
Hyun LeeHyun Lee
Hyun Lee
YPYeonkyung Park
Yeonkyung Park
SCSung Jun Chung
Sung Jun Chung
YYYoomi Yeo
Yoomi Yeo
JMJi-Yong MOON
Ji-Yong MOON
Kim Y, et al. Allergy Asthma Immunol Res. 2021 Sep;13(5):808-816. https://doi.org/10.4168/aair.2021.13.5.808

1 January 2021 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
Hyun LeeHyun Lee
Hyun Lee
JRJiin Ryu
Jiin Ryu
SCSung Jun Chung
Sung Jun Chung
YYYoomi Yeo
Yoomi Yeo
TPTai Sun Park
Tai Sun Park
SKSang-Heon Kim
Sang-Heon Kim
Lee H, et al. Allergy Asthma Immunol Res. 2021 Nov;13(6):945-953. https://doi.org/10.4168/aair.2021.13.6.945

15 December 2020 in Allergy
Verified
Journal Article
Closed access
PDF file
Hyun LeeHyun Lee
Hyun Lee
HCHayoung Choi
Hayoung Choi
HNHyewon Nam
Hyewon Nam
BYBumhee Yang
Bumhee Yang
BHBin Hwangbo
Bin Hwangbo
SKSang-Heon Kim
Sang-Heon Kim

1 January 2024 in Allergy, Asthma & Immunology Research
Verified
Journal Article
Open access
PDF file
KHKyung-Il Han
Kyung-Il Han
Hyun LeeHyun Lee
Hyun Lee
BKBo-Guen Kim
Bo-Guen Kim
YYYoomi Yeo
Yoomi Yeo
TPTai Sun Park
Tai Sun Park
TKTae-Hyung Kim
Tae-Hyung Kim
Han KI, et al. Allergy Asthma Immunol Res. 2024 May;16(3):291-299. https://doi.org/10.4168/aair.2024.16.3.291